• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Top Chinese virologist slams China’s ‘COVID Zero’ policy in rare sign of domestic dissent

By
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Bloomberg
Bloomberg
Down Arrow Button Icon
November 10, 2021, 7:21 AM ET

A top Chinese virologist warned the country risks economic collapse if local officials continue to try to wipe out all traces of COVID-19, marking the most vocal criticism of China’s so-called COVID Zero approach by one of its own experts.

Guan Yi, a virologist at the University of Hong Kong, disparaged China’s effort to eliminate sporadic flareups of the virus through mass testing and lengthy quarantines. In the wide-ranging interview with Hong Kong-based Phoenix Satellite TV, he urged a reality-check on how well an extensive vaccination drive helped the world’s most populous country build immunity to COVID. 

“We don’t stand a chance if we pursue a target of zero COVID,” said Guan, who’s been dubbed the “virus hunter” by the Chinese media for his work on identifying the animal origins of the coronaviruses that caused SARS and MERS. “The virus is here today, just like flu. That’s a fact, whether people like it or not.”

The ability to break away from COVID Zero hinges on the effectiveness of the vaccines and the cost of controlling the virus, Guan said. It’s crucial for China to figure out how much protection its mass vaccination program has afforded the population, he said.

“Let’s not roll out nucleic acid testing for everyone at every turn,” he said. “I think it’s testing antibodies that matters. Everybody should know where their immunity is at.”

Guan’s comments are a rare, high-profile criticism from within the country’s elite of its lingering adherence to COVID Zero, which other adherents like Singapore and Australia have abandoned as the more transmissible delta variant makes it almost impossible to maintain. The criticism follows on the heels of an emotional plea for support made by the former vice mayor of a border town called Ruili in southwestern China, where repetitive lockdowns after COVID incursions from Myanmar are threatening livelihoods and exhausting local officials.

Officials in China have said they still consider squashing domestic flareups with aggressive curbs a better option for people’s safety and the economy’s health than reopening borders and easing restrictions. The country will maintain stringent curbs at least through spring given the outbreaks beyond its borders, health officials said in Beijing on Saturday. 

It’s also doubling-down on vaccinations. More than 75% of the country is fully protected and authorities are rolling out booster shots to all adults. Immunizations are now available to children as young as three years old. 

Still, Guan questioned the impact of vaccination in China when local governments won’t relent on controls such as quarantine and temperature screening. While taking temperatures is ubiquitous across the country, the virologist said that’s a “lagging defense” because infected people can spread the virus without showing any symptoms. 

“Don’t blame the virus for being stealthy,” he said. “We just consider ourselves smarter than we really are.” 

Instead, Guan said the country must develop a clearer understanding about how the homegrown vaccines are working against new variants of the virus. It should “kick out vaccines that have become ineffective,” he said. 

China’s leading shots, from state-backed Sinopharm and Sinovac Biotech Ltd., use traditional vaccine technology. While clinical trials show them to be effective at preventing severe cases of COVID, hospitalizations and deaths, they are less reliable than Western mRNA shots at stopping transmission and reducing overall case counts. 

“One can tell what’s good or bad through comparison,” Guan said. “If we fail to recognize our shortcomings, we lack the incentive to make progress.”

More health care and Big Pharma coverage from Fortune:

  • Biden’s vaccine mandate may be tied up in court—but employers shouldn’t wait to enforce it, say legal experts
  • State Farm publicly supports NFL’s Aaron Rodgers after his vaccine comments—while quietly removing most of his ads
  • How Big Bird became the unlikely target of GOP senators
  • Denmark ditched its COVID rules 2 months ago. Now cases are up—and restrictions are coming back
  • Air purifiers and CO2 monitors are the new pencil and paper in classrooms

Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.

About the Author
By Bloomberg
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

HealthDietary Supplements
5 Best Nootropics of 2026: Expert Reviewed Supplements
By Christina SnyderFebruary 13, 2026
10 hours ago
Big TechGen Z
Analog-obsessed Gen Zers are buying $40 app blockers to limit their social media use and take a break from the ‘slot machine in your pocket’
By Marco Quiroz-GutierrezFebruary 13, 2026
10 hours ago
Leesa Sapira Chill
Healthmattresses
Presidents Day Mattress Sales 2026: Find Deals on the Best Sleep Brands
By Christina SnyderFebruary 13, 2026
12 hours ago
dog
CommentaryAnimals
You love your dog too much. Blame the broken American Dream and loss of purpose since the pandemic
By Margret Grebowicz and The ConversationFebruary 13, 2026
15 hours ago
Healthsleep
Leesa Mattress Review (2026): Rigorously Tested
By Christina SnyderFebruary 12, 2026
1 day ago
Healthsleep
WinkBeds Mattress Review (2026): Rigorously Tested
By Christina SnyderFebruary 11, 2026
2 days ago

Most Popular

placeholder alt text
Economy
Some folks on Wall Street think yesterday’s U.S. jobs number is ‘implausible’ and thus due for a downward correction
By Jim EdwardsFebruary 12, 2026
2 days ago
placeholder alt text
Economy
‘Nothing short of self-sabotage’: Watchdog warns about national debt setting new record in just 4 years
By Tristan BoveFebruary 11, 2026
2 days ago
placeholder alt text
North America
‘I gave another girl to Kimbal’: Inside Jeffrey Epstein’s honey-trap plan targeting Elon Musk through his brother
By Eva Roytburg and Jessica MathewsFebruary 13, 2026
13 hours ago
placeholder alt text
Commentary
Something big is happening in AI — and most people will be blindsided
By Matt ShumerFebruary 11, 2026
3 days ago
placeholder alt text
Success
Actress Jennifer Garner just took her $724 million organic food empire public. She started her career making just $150 weekly as a ‘broke’ understudy
By Emma BurleighFebruary 13, 2026
13 hours ago
placeholder alt text
Success
Ex–Google exec says degrees in law and medicine are a waste of time because they take so long to complete that AI will catch up by graduation
By Preston ForeFebruary 11, 2026
3 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.